repeat
test
patient
suspicion
infect
given
patient
could
initi
rtpcr
falseneg
result
systemat
review
registr
protocol
avail
osf
websit
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
background
decemb
world
health
organ
alert
cluster
pneumonia
patient
citi
wuhan
china
hubei
provinc
chines
author
confirm
week
later
outbreak
novel
coronaviru
current
call
sever
acut
respiratori
coronaviru
new
viru
underli
caus
coronaviru
diseas
becom
worldwid
public
health
emerg
reach
pandem
statu
time
articl
write
viru
spread
countri
territori
caus
death
worldwid
patient
exhibit
respiratori
symptom
fever
cough
short
breath
primari
manifest
although
case
present
mild
symptom
case
develop
pneumonia
sever
respiratori
diseas
kidney
failur
even
death
mainli
spread
persontoperson
contact
via
respiratori
droplet
cough
sneez
surfac
contamin
droplet
recent
studi
suggest
presenc
asymptomat
case
cluster
famili
possibl
transmit
viru
viruscarri
person
display
symptom
sign
infect
mention
nonspecif
confirm
case
current
base
detect
viral
sequenc
revers
transcriptionpolymeras
chain
reaction
differ
rtpcr
scheme
propos
includ
n
gene
code
viral
nucleocapsid
altern
target
e
gene
viral
envelop
gene
spike
hel
gene
rna
polymeras
gene
rdrphelicas
molecular
criteria
vitro
diagnosi
diseas
heterogen
usual
requir
detect
two
gene
rtpcr
repeat
test
might
requir
confirm
clinic
diagnosi
especi
presenc
symptom
close
relat
diseas
case
neg
rtpcr
result
initi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
test
later
found
posit
subsequ
test
commonli
consid
case
initi
falseneg
result
research
suggest
failur
detect
relat
multipl
preanalyt
analyt
factor
lack
standardis
collect
specimen
time
conserv
sampl
receiv
laboratori
use
nonadequ
valid
assay
contamin
procedur
insuffici
viral
specimen
load
incub
period
diseas
risk
activ
recombin
mutat
avail
accur
laboratori
tool
essenti
case
identif
contact
trace
optim
infect
control
measur
shown
previou
epidem
caus
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
due
pandem
caus
import
burden
health
system
around
globe
consid
miss
covid
case
might
sever
consequ
sever
level
aim
estim
systemat
review
literatur
proport
falseneg
relat
detect
use
rtpcr
assay
initi
laboratori
test
follow
prefer
report
item
systemat
review
metaanalys
prisma
diagnost
test
accuraci
dta
perform
report
develop
systemat
review
literatur
use
select
method
develop
rapid
review
high
involv
stakehold
review
process
includ
definit
review
question
nonindepend
verif
data
select
extract
parallelis
task
perform
select
activ
simultan
instead
consecut
review
shortcut
omiss
review
task
appli
protocol
review
publish
open
scienc
framework
repositori
public
consult
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
criteria
consid
studi
review
includ
observ
studi
includ
accuraci
studi
cohort
case
seri
report
initi
use
rtpcr
detect
rna
patient
suspicion
infect
clinic
epidemiolog
criteria
special
prioritis
studi
enrol
consecut
patient
receiv
rtpcr
initi
test
confirm
infect
andor
diagnosi
positiveneg
impos
limit
age
gender
studi
locat
aim
includ
type
rtpcr
kit
regardless
brandmanufactur
rna
extract
method
use
number
target
gene
assay
assess
cycl
threshold
valu
posit
studi
compar
accuraci
two
test
diagnosi
also
consid
could
abstract
fraction
neg
test
result
defin
initi
rtpcr
assay
exclud
studi
without
clear
inform
falseneg
case
number
final
confirm
case
unclear
verif
neg
case
case
report
studi
base
laboratori
sampl
literatur
review
also
exclud
carri
comprehens
sensit
search
strategi
base
propos
live
systemat
review
develop
univers
bern
institut
social
prevent
ispm
follow
databas
medlin
ovid
sp
april
th
embas
ovid
sp
april
th
lilac
iah
english
birem
april
th
appli
languag
restrict
electron
search
appendix
addit
sourc
potenti
studi
search
repositori
preprint
articl
medrxiv
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
select
potenti
studi
one
review
screen
search
result
base
titl
abstract
addit
verif
second
review
noindepend
verif
retriev
fulltext
copi
studi
assess
potenti
elig
pair
review
confirm
elig
accord
select
criteria
nonindepend
verif
case
disagr
reach
consensu
discuss
data
extract
one
review
extract
qualit
quantit
data
elig
studi
addit
review
check
extract
inform
accuraci
nonindepend
verif
data
extract
assess
methodolog
qualiti
accuraci
studi
use
qualiti
assess
diagnost
accuraci
studi
tool
due
lack
tool
assess
risk
bia
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
associ
case
seri
decid
appli
tool
case
inclus
type
report
includ
studi
extract
data
number
case
initi
consid
neg
ie
falseneg
case
well
total
confirm
case
investig
present
result
estim
proport
ci
forest
plot
order
assess
betweenstudi
variabl
aim
calcul
falseneg
rate
correspond
ci
use
multilevel
mixedeffect
logist
regress
model
implement
stata
metapropon
command
allow
us
estim
betweenstudi
heterogen
varianc
studyspecif
random
intercept
assess
heterogen
result
primari
studi
use
tausquar
statist
probabl
valu
less
p
consid
suggest
statist
signific
heterogen
preclud
pool
result
numer
data
plan
investig
potenti
sourc
heterogen
use
descript
approach
perform
randomeffect
metaregress
analysi
anticip
sourc
heterogen
includ
type
specimen
collect
presenc
clinic
find
number
rna
target
gene
assess
time
symptom
evolut
rate
certainti
evid
falseneg
case
follow
grade
approach
test
strategi
assess
qualiti
evid
high
moder
low
low
depend
sever
factor
includ
risk
bia
imprecis
inconsist
indirect
public
bia
illustr
consequ
numer
find
popul
test
accord
three
differ
preval
estim
diseas
provid
stakehold
involv
review
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
patient
public
involv
involv
sever
stakehold
design
conduct
report
research
includ
gener
famili
physician
specialist
infecti
diseas
microbiologist
current
attend
patient
suspicion
covid
diseas
studi
protocol
preliminari
result
publicli
avail
http
age
particip
rang
year
inform
deriv
three
studi
men
versu
women
includ
tabl
three
studi
includ
patient
suspicion
due
clinic
find
andor
epidemiolog
criteria
confirm
infect
perform
isol
realtim
rtpcr
assay
includ
repeat
rtpcr
neg
result
two
three
studi
provid
inform
proport
confirm
case
posit
chest
ct
find
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
rang
one
studi
provid
inform
time
symptom
onset
ct
scan
proxi
durat
diseas
second
one
report
durat
fever
regard
rtpcr
test
rtpcr
brandmanufactur
report
two
studi
studi
report
criteria
posit
studi
base
assess
throat
sampl
pharyng
nasal
oropharyng
swab
four
studi
provid
inform
time
sinc
initi
rtpcr
repeat
test
tabl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
appli
quadasii
tool
includ
studi
reflect
critic
limit
valid
find
figur
appendix
refer
standard
domain
affect
potenti
risk
bia
due
lack
independ
index
test
confirm
case
repeat
rtpcr
test
detail
criteria
posit
provid
includ
studi
domain
judg
unclear
risk
unclear
applic
concern
addit
applic
patient
select
judg
great
concern
due
studi
select
patient
underw
rtpcr
chest
ct
exclud
patient
candid
receiv
index
test
current
clinic
practic
pool
estim
falseneg
proport
ci
estim
mixedeffect
logist
regress
model
howev
pool
data
affect
consider
betweenstudi
heterogen
tausquar
ci
p
sinc
abl
warrant
averag
estim
provid
metaanalysi
valid
repres
estim
true
valu
falseneg
proport
current
practic
instead
use
rang
proport
analysi
certainti
evid
use
grade
approach
full
explor
heterogen
possibl
given
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
studi
collect
upper
lower
respiratori
specimen
b
studi
includ
patient
clinic
find
suggest
covid
diseas
c
subgroup
inform
time
evolut
symptom
provid
one
studi
key
inform
characterist
index
test
posit
criteria
report
high
variabl
pool
estim
reduc
separ
estim
falseneg
proport
type
studi
accuraci
versu
case
seri
use
rang
falseneg
proport
develop
summari
find
follow
grade
approach
qualiti
evid
judg
low
due
issu
relat
risk
bia
indirect
inconsist
figur
illustr
consequ
rang
falseneg
proport
popul
test
accord
three
differ
preval
seen
current
clinic
practic
particip
stakehold
figur
use
preval
found
case
would
misdiagnos
could
receiv
adequ
clinic
manag
could
requir
repeat
test
point
hospit
even
could
requir
investig
competit
diagnos
numer
approach
interpret
caution
due
multipl
limit
evid
describ
figur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
find
rtpcr
chest
ct
sever
provinc
china
collect
januari
februari
consid
studi
affect
sever
sourc
bia
especi
relat
independ
index
test
refer
standard
unclear
report
key
rtpcr
characterist
metaanalysi
proport
use
show
consider
heterogen
explain
collect
data
variabl
limit
full
interpret
averag
proport
altern
prefer
provid
analysi
rang
falseneg
proport
deriv
includ
studi
cohort
patient
test
use
three
differ
preval
diseas
deriv
current
clinic
practic
particip
stakehold
use
preval
found
case
would
misdiagnos
could
receiv
adequ
clinic
manag
howev
emphas
numer
approach
interpret
caution
due
multipl
limit
evid
describ
qualiti
evid
low
although
impos
restrict
popul
characterist
age
set
public
statu
notic
find
limit
due
studi
perform
one
countri
china
report
data
begin
pandem
januari
addit
lack
report
index
test
previous
mention
rtpcr
kit
use
includ
studi
like
first
kit
develop
detect
test
current
use
might
great
technolog
evolv
differ
characterist
initi
tool
despit
scarciti
inform
answer
review
question
studi
carri
comprehens
literatur
search
identifi
relev
studi
includ
sever
sourc
unpublish
literatur
preprint
repositori
assess
also
includ
rigor
assess
potenti
sourc
bia
formal
statist
analysi
result
final
assess
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
certainti
evid
wellknown
system
grade
appli
select
method
associ
rapid
review
streamlin
review
process
involv
stakehold
develop
review
nonindepend
verif
data
select
extract
parallelis
task
conduct
select
activ
simultan
instead
consecut
avoid
use
method
potenti
might
affect
qualiti
review
process
relat
limit
search
strategi
omiss
qualiti
assess
collect
evid
narr
synthesi
result
due
perman
involv
clinician
manag
covid
patient
develop
review
abl
defin
review
question
respond
clinic
inquiri
relev
current
clinic
practic
fact
number
case
misdiagnos
target
condit
critic
figur
due
sever
consequ
treatment
miss
patient
estim
also
help
estim
addit
resourc
current
clinic
practic
confirm
suspici
case
find
reinforc
need
repeat
test
patient
suspicion
infect
due
either
clinic
epidemiolog
reason
given
patient
may
initi
neg
rtpcr
certainti
evid
low
collect
evid
sever
limit
term
risk
bia
applic
addit
lack
report
sever
key
factor
remain
signific
constraint
analysi
collect
data
fals
neg
result
recov
phase
could
import
implic
isol
risk
transmiss
although
risk
reduc
document
least
two
neg
sampl
discharg
consequ
posit
result
could
also
erron
consid
reinfect
updat
review
new
studi
would
avail
warrant
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
due
multipl
difficulti
associ
lack
report
includ
studi
due
high
probabl
new
studi
publish
shortterm
provid
recommend
futur
studi
candid
includ
updat
review
inclus
seri
consecut
patient
instead
select
group
avoid
spectrum
bia
inclus
seri
consecut
patient
instead
select
group
avoid
spectrum
bia
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
